John Hermanek, MBA

John Hermanek joined Immatics in April 2025 and is responsible for the company’s global planning and execution of all market access and government affairs activities as the company advances its TCR-based product candidates towards commercialization.

John is an accomplished commercial biopharmaceutical executive with over 20 years of leadership experience across the U.S. and global markets. He has led high-performing Commercial and Market Access teams focused on delivering impactful access solutions for patients and providers. His expertise spans pricing and reimbursement strategy, innovative contracting, payer marketing and health policy.

John brings a policy-informed perspective to market access, shaped by five years of public sector service with the State of Illinois and further developed in policy leadership roles at Amgen during key healthcare reform periods. Throughout his career, he has prioritized cross-functional collaboration and evidence planning to align payer needs with clinical value, supporting timely and appropriate access to new therapies across oncology, autoimmune, neurology and rare disease. His work is driven by a commitment to equitable access and outcomes-oriented strategies.

John Hermanek holds an MBA from the Kellogg School of Management at Northwestern University, and a Bachelor of Science degree from Northwestern University.